keyword
https://read.qxmd.com/read/38828721/combining-sirp%C3%AE-decoy-coengineered-t-cells-and-antibodies-augments-macrophage-mediated-phagocytosis-of-tumor-cells
#21
JOURNAL ARTICLE
Evangelos Stefanidis, Aikaterini Semilietof, Julien Pujol, Bili Seijo, Kirsten Scholten, Vincent Zoete, Olivier Michielin, Raphael Sandaltzopoulos, George Coukos, Melita Irving
The adoptive transfer of T cell receptor-engineered (TCR-engineered) T cells (ACT) targeting the HLA-A2-restricted cancer-testis epitope NY-ESO-1157-165 (A2/NY) has yielded favorable clinical responses against several cancers. Two approaches to improve ACT are TCR affinity optimization and T cell coengineering to express immunomodulatory molecules that can exploit endogenous immunity. By computational design we previously developed a panel of binding-enhanced A2/NY-TCRs including A97L, which augmented the in vitro function of gene-modified T cells as compared with WT...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38828693/ube2c-as-an-immune-related-biomarker-for-breast-cancer-a-study-based-on-multiple-databases
#22
JOURNAL ARTICLE
Yue Cui, Hong-Zhi Wang, Ye Song, Shuang Yang, Feng-Ying Sai, De-Jun Yu
Objective To screen the target gene UBE2C and explore its prognostic value and immune correlation in breast cancer (BRCA) using multiple databases. Methods The microarray expression datasets of BRCA were downloaded from the Gene Expresssion Omnibus database (GEO) and analyzed to obtain differentially expressed genes (DEGs). Hub genes were obtained by constructing and visualizing the protein-protein interaction network of DEGs. Then the key gene UBE2C was determined using R language, STRING, and Cytoscape, and the differential expression of UBE2C was verified using the external datasets, The Cancer Genome Atlas (TCGA) , and quantitative real-time PCR (qRT-PCR)...
May 20, 2024: Chinese Medical Sciences Journal
https://read.qxmd.com/read/38828508/the-spillover-effects-of-extending-liver-transplantation-to-patients-with-colorectal-liver-metastases-a-discrete-event-simulation-analysis
#23
JOURNAL ARTICLE
Hanna Meidell Sjule, Caroline N Vinter, Svein Dueland, Pål-Dag Line, Emily A Burger, Gudrun Marie Waaler Bjørnelv
BACKGROUND: Liver transplantation is an alternative treatment for patients with nonresectable colorectal cancer liver-only metastases (CRLM); however, the potential effects on wait-list time and life expectancy to other patients on the transplant waiting list have not been considered. We explored the potential effects of expanding liver transplantation eligibility to include patients with CRLM on wait-list time and life expectancy in Norway. METHODS: We developed a discrete event simulation model to reflect the Norwegian liver transplantation waiting list process and included 2 groups: 1) patients currently eligible for liver transplantation and 2) CRLM patients...
June 3, 2024: Medical Decision Making: An International Journal of the Society for Medical Decision Making
https://read.qxmd.com/read/38828494/nomogram-for-predicting-survival-in-locally-advanced-cervical-cancer-with-concurrent-chemoradiotherapy-plus-or-not-adjuvant-chemotherapy-a-retrospective-analysis-based-on-2018-figo-staging
#24
JOURNAL ARTICLE
Li Hua, Mengzhuan Wei, Chengjun Feng, Shiting Li, Xiaomin Wen, Shaojun Chen
Background: The comprehensive treatment mode of combining concurrent chemoradiotherapy (CCRT) with adjuvant chemotherapy (AC) is a commonly used mainstream model in the clinical practice of locally advanced cervical cancer (LACC). However, the necessity for AC after CCRT lacks sufficient evidence-based medical support. This study constructs a predictive model for the survival time dependence of CCRT ± AC for LACC based on the 2018 International Federation of Gynecology and Obstetrics (FIGO) staging with internal validation, the prognosis was assessed with intensity-modulated radiotherapy (IMRT) and concurrent cisplatin, and provides guidance for future stratified treatment...
June 3, 2024: Cancer Biotherapy & Radiopharmaceuticals
https://read.qxmd.com/read/38828390/non-canonical-mrna-translation-initiation-in-cell-stress-and-cancer
#25
REVIEW
Mélanie Mahé, Tiffany Rios-Fuller, Olga Katsara, Robert J Schneider
The now well described canonical mRNA translation initiation mechanism of m7 G 'cap' recognition by cap-binding protein eIF4E and assembly of the canonical pre-initiation complex consisting of scaffolding protein eIF4G and RNA helicase eIF4A has historically been thought to describe all cellular mRNA translation. However, the past decade has seen the discovery of alternative mechanisms to canonical eIF4E mediated mRNA translation initiation. Studies have shown that non-canonical alternate mechanisms of cellular mRNA translation initiation, whether cap-dependent or independent, serve to provide selective translation of mRNAs under cell physiological and pathological stress conditions...
June 2024: NAR cancer
https://read.qxmd.com/read/38828350/a-prognostic-binary-classifier-comprised-of-five-critical-mrnas-stratified-pancreatic-cancer-patients-following-resection
#26
JOURNAL ARTICLE
Yueqing Lu, Tong Zhou, Mingshu Lu
BACKGROUND: Pancreatic cancer is characterized by an extremely poor prognosis, even following potentially curative resection. Classical prognostic markers such as histopathological or clinical parameters have limited predictive power. The present study aimed to establish a prognostic model combining mRNA expression data with histopathological and clinical data to better predict survival and stratify pancreatic cancer patients following resection. We pioneered three models in one study and systematically evaluated the clinical benefits of all three models...
June 15, 2024: Heliyon
https://read.qxmd.com/read/38828257/clinicopathological-features-and-outcomes-of-endometrial-cancer-a-single-institution-experience
#27
JOURNAL ARTICLE
Ikram A Burney, Shahd Al Ghafri, Jawahar Al Noumani, Anisa Al Jabri, Anjum O Hasan, Sarya Bella, Hasan Al-Sayegh, Radhiya Al Ajmi, Moza Al Kalbani
OBJECTIVES: This study aimed to report the demographic features, clinical presentation, pathological types and long-term outcomes of patients diagnosed with endometrial cancer (EC) in Oman. EC is the sixth most common cancer in women worldwide and the fifth most common cancer in women in Oman. Survival outcomes of EC have not been reported previously from Oman. METHODS: This retrospective study was carried out on consecutive patients treated at the Sultan Qaboos University Hospital, Muscat, Oman, between 2008 and 2020...
May 2024: Sultan Qaboos University Medical Journal
https://read.qxmd.com/read/38828252/managing-the-adverse-events-associated-with-pembrolizumab-and-lenvatinib-therapy-in-endometrial-cancer
#28
JOURNAL ARTICLE
Aref Zribi, Khulood Al Riyami, Hajar S Al Zahibi, Ikram A Burney
Endometrial cancer (EC) is the most common gynaecological cancer. The combination of lenvatinib and pembrolizumab has exhibited efficacy as the second line treatment for advanced EC, with a significant benefit in terms of progression free survival (PFS) and overall survival, but the adverse events (AE) profile is complex. AEs associated with the treatment may represent a limitation to this combination. Here, we report the case of a 38-year-old female patient diagnosed with stage IV EC elsewhere, whose disease progressed after the first line of treatment and was referred to a specialised cacncer centre in Muscat, Oman, in 2021...
May 2024: Sultan Qaboos University Medical Journal
https://read.qxmd.com/read/38828148/suppressing-wnt-signaling-of-the-blood%C3%A2-tumor-barrier-to-intensify-drug-delivery-and-inhibit-lipogenesis-of-brain-metastases
#29
JOURNAL ARTICLE
Yang Tong, Pei An, Puxian Tang, Rui Mu, Yuteng Zeng, Hang Sun, Mei Zhao, Ziyan Lv, Pan Wang, Wanjun Han, Chunshan Gui, Xuechu Zhen, Liang Han
Lipogenesis is often highly upregulated in breast cancer brain metastases to adapt to intracranial low lipid microenvironments. Lipase inhibitors hold therapeutic potential but their intra-tumoral distribution is often blocked by the blood‒tumor barrier (BTB). BTB activates its Wnt signaling to maintain barrier properties, e.g. , Mfsd2a-mediated BTB low transcytosis. Here, we reported VCAM-1-targeting nano-wogonin (W@V-NPs) as an adjuvant of nano-orlistat (O@V-NPs) to intensify drug delivery and inhibit lipogenesis of brain metastases...
June 2024: Acta Pharmaceutica Sinica. B
https://read.qxmd.com/read/38828138/directly-targeting-bax-for-drug-discovery-therapeutic-opportunities-and-challenges
#30
REVIEW
Zhenwei Zhang, Linghui Hou, Dan Liu, Shenglin Luan, Min Huang, Linxiang Zhao
For over two decades, the development of B-cell lymphoma-2 (Bcl-2) family therapeutics has primarily focused on anti-apoptotic proteins, resulting in the first-in-class drugs called BH3 mimetics, especially for Bcl-2 inhibitor Venetoclax. The pro-apoptotic protein Bcl-2-associated X protein (BAX) plays a crucial role as the executioner protein of the mitochondrial regulated cell death, contributing to organismal development, tissue homeostasis, and immunity. The dysregulation of BAX is closely associated with the onset and progression of diseases characterized by pathologic cell survival or death, such as cancer, neurodegeneration, and heart failure...
June 2024: Acta Pharmaceutica Sinica. B
https://read.qxmd.com/read/38828132/colorectal-cancer-screening-participation-in-first-nations-populations-worldwide-a-systematic-review-and-data-synthesis
#31
JOURNAL ARTICLE
Lily A Pham, Paul J Clark, Graeme A Macdonald, James A Thomas, Christine Dalais, Annie Fonda, Bradley J Kendall, Aaron P Thrift
BACKGROUND: First Nations populations have poorer colorectal cancer (CRC) survival compared to non-First Nations populations. Whilst First Nations populations across the world are distinct, shared experiences of discrimination and oppression contribute to persistent health inequities. CRC screening improves survival, however screening rates in First Nations populations are poorly described. This study seeks to define participation rates in CRC screening in First Nations populations worldwide...
July 2024: EClinicalMedicine
https://read.qxmd.com/read/38827936/ayurveda-rasayana-therapy-art-leads-to-tumor-regression-and-increased-survival-in-chemo-intolerance-high-grade-stage-iv-follicular-lymphoma-a-case-study
#32
Yogesh Narayan Bendale, Poonam Birari-Gawande, Anandrao Patil, Avinash Kadam
KEY CLINICAL MESSAGE: Ayurveda Rasayana Therapy (ART) may serve as a safe and effective alternative treatment option for chemo-intolerance high-grade stage IV follicular lymphoma patients for increasing survival and tumor regression. ABSTRACT: Follicular lymphoma (FL), also called follicle center lymphoma/nodular lymphoma, observed in the B lymphocytes (B-cells). Available therapeutic options for follicular lymphoma are associated with various side effects and, patients with co-morbidities can seldom tolerate the chemotherapy regimens...
June 2024: Clinical Case Reports
https://read.qxmd.com/read/38827885/esophageal-cancer-patient-survival-a-retrospective-study-from-a-tertiary-care-hospital-in-pakistan
#33
JOURNAL ARTICLE
Sajida Qureshi, Sumayah Khan, M Saeed Quraishy, Sidra Zaheer
OBJECTIVE: To determine the pattern, tumor characteristics of esophageal cancer (EC) and survival of esophageal carcinoma patients presenting to upper GI Unit at Dr. Ruth K.M. Pfau Civil Hospital Karachi. METHODS: We conducted a retrospective analysis of histologically confirmed EC patients from 2016 to 2021 at Upper GI Unit - Dr. Ruth K.M. Pfau Civil Hospital, Karachi. Data were collected using a filled Proforma, medical records, pathology reports and surgical notes, and patients or their family members were contacted for informed consent...
2024: Pakistan Journal of Medical Sciences Quarterly
https://read.qxmd.com/read/38827878/demographic-characteristics-and-short-term-outcomes-of-laparoscopic-colon-cancer-surgeries-at-a-newly-developed-cancer-center-in-peshawar-pakistan
#34
JOURNAL ARTICLE
Riaz Ahmad, Hussain Jan Abbasi, Irfan Ul Islam Nasir, Muhammad Fahd Shah
OBJECTIVE: In Pakistan, colon cancer ranks fourth in incidence, exhibiting survival rates of 90% to 14%, contingent on TNM staging and early detection. This research focuses on the demographic involvement and short-term outcomes of elective colon cancer resections at a newly established tertiary care cancer center utilizing laparoscopic procedures. METHOD: A retrospective analysis of elective laparoscopic colorectal resections at Shaukat Khanum Memorial Cancer Institute and Research Centre, Peshawar, from April 2021 to February 2022 was conducted...
2024: Pakistan Journal of Medical Sciences Quarterly
https://read.qxmd.com/read/38827861/early-response-and-outcomes-of-bone-marrow-to-chemotherapy-in-t-cell-acute-lymphoblastic-leukemia
#35
JOURNAL ARTICLE
May AlMoshary, Shatha Mahmoud Altahan, Aziza Fayed Alswayyed
OBJECTIVES: To evaluate the outcomes (relapse and mortality rate) and response of the bone marrow in early stages after combination chemotherapy in patients with T-cell Acute Lymphoblastic Leukemia (T-ALL). METHODS: A descriptive cross-sectional study was conducted at King Fahad Medical City, from January 2021 to December 2022, to evaluate bone marrow findings at the time of diagnosis and post-chemotherapy in 26 patients diagnosed with T-ALL. The study included all patients diagnosed with T-ALL of any age group during the study period...
2024: Pakistan Journal of Medical Sciences Quarterly
https://read.qxmd.com/read/38827823/identification-and-validation-of-nicotinamide-metabolism-related-gene-signatures-as-a-novel-prognostic-model-for-hepatocellular-carcinoma
#36
JOURNAL ARTICLE
Sijia Yang, Ang Li, Lihong Lv, Jinxin Duan, Zhihua Zheng, Wenfeng Zhuo, Jun Min, Jinxing Wei
BACKGROUND: Nicotinamide (NAM+) regulates redox and metabolic activities in the mitochondria. The intention of the research was to identify key genes that relate to nicotinamide in hepatocellular carcinoma (HCC). METHODS: Relevant clinical information were collected as well as RNA-seq data using the Cancer Genome Atlas (TCGA) database. Differential analysis was used to discover the genes that were differently expressed. On the key genes associated with NAM, functional enrichment analysis was carried out...
2024: OncoTargets and Therapy
https://read.qxmd.com/read/38827805/prognostic-and-clinicopathological-significance-of-foxd1-in-various-cancers-a-meta-and-bioinformation-analysis
#37
REVIEW
Xiaohan Liu, Shengyun Min, Qin Zhang, Yan Liu, Zhenhong Zou, Nanye Wang, Bin Zhou
Aim: To examine both predictive and clinicopathological importance underlying FOXD1 in malignant tumors, our study adopts meta-analysis. Methods: We searched from PubMed, Embase, WOS, Wanfang and CNKI. Stata SE15.1 was used to calculate the risk ratio (HR) as well as relative risk (RR) with 95% of overall CIs to assess FOXD1 and overall survival rate (OS), disease-free survival rate as well as clinicopathological parameters. Results: 3808 individuals throughout 17 trials showed high FOXD1 expression was linked to disadvantaged OS (p < 0...
2024: Future Science OA
https://read.qxmd.com/read/38827800/marital-status-impacts-survival-of-stage-i-non-small-cell-lung-cancer-a-propensity-score-matching-analysis
#38
JOURNAL ARTICLE
Li-Hong Qiu, Jia-Qi Song, Feng Jiang, Yuan-Yuan Zhao, Yu'e Liu, Lei-Lei Wu, Guo-Wei Ma
Aim: This population-based analysis aimed to explore the associations among marital status, prognosis and treatment of stage I non-small-cell lung cancer. Materials & methods: The propensity score matching (PSM), logistic regression and Cox proportional hazards model were used in this study. Results: A total of 13,937 patients were included. After PSM, 10579 patients were co-insured. The married were more likely to receive surgical treatment compared with the unmarried patients (OR: 1.841, p < 0...
2024: Future Science OA
https://read.qxmd.com/read/38827797/prognostic-predictive-value-of-ki-67-in-stage-i-ii-triple-negative-breast-cancer
#39
JOURNAL ARTICLE
Fengyan Li, Xinhui Zhou, Wendie Hu, Yujie Du, Jiayuan Sun, Yaxue Wang
Aim: Our research aimed to determine an optimal cutoff value and investigate the prognostic predictive function of Ki-67. Materials & methods: We retrospectively enrolled 1146 patients diagnosed with stage I-II triple-negative breast cancer. Disease-free and overall survival were analyzed using the Kaplan-Meier method and the Cox regression model. Results: We classified Ki-67 >45% as the high group (n = 716). A Ki-67 level of >45% was associated with poorer disease-free survival (p = 0...
2024: Future Science OA
https://read.qxmd.com/read/38827785/deguelin-restores-paclitaxel-sensitivity-in-paclitaxel-resistant-ovarian-cancer-cells-via-inhibition-of-the-egfr-signaling-pathway
#40
JOURNAL ARTICLE
Seunghee Bae, Sowon Bae, Hee Su Kim, Ye Jin Lim, Gyeongmi Kim, In-Chul Park, Kyeong A So, Tae Jin Kim, Jae Ho Lee
BACKGROUND: Ovarian cancer is one of women's malignancies with the highest mortality among gynecological cancers. Paclitaxel is used in first-line ovarian cancer chemotherapy. Research on paclitaxel-resistant ovarian cancer holds significant clinical importance. METHODS: Cell viability and flow cytometric assays were conducted at different time and concentration points of deguelin and paclitaxel treatment. Immunoblotting was performed to assess the activation status of key signaling molecules important for cell survival and proliferation following treatment with deguelin and paclitaxel...
2024: Cancer Management and Research
keyword
keyword
11400
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.